BIOMARKER:

EGFR exon 20 mutation

Entrez ID:

Related biomarkers:

‹

›

EGFR exon 20 mutation EGFR exon 20 mutation	Solid Tumor Solid Tumor	EGFR exon 20 mutation EGFR exon 20 mutation	Solid Tumor Solid Tumor	tarloxotinib bromide Sensitive: C2 – Inclusion Criteria	tarloxotinib bromide Sensitive: C2 – Inclusion Criteria
EGFR exon 20 mutation EGFR exon 20 mutation	Non Small Cell Lung Cancer NSCLC	EGFR exon 20 mutation EGFR exon 20 mutation	Non Small Cell Lung Cancer NSCLC	erlotinib Sensitive: C2 – Inclusion Criteria	erlotinib Sensitive: C2 – Inclusion Criteria
EGFR exon 20 mutation EGFR exon 20 mutation	Non Small Cell Lung Cancer NSCLC	EGFR exon 20 mutation EGFR exon 20 mutation	Non Small Cell Lung Cancer NSCLC	AST2818 Sensitive: C2 – Inclusion Criteria	AST2818 Sensitive: C2 – Inclusion Criteria
EGFR exon 20 mutation EGFR exon 20 mutation	Non Small Cell Lung Cancer NSCLC	EGFR exon 20 mutation EGFR exon 20 mutation	Non Small Cell Lung Cancer NSCLC	Immunotherapy Sensitive: C3 – Early Trials	Immunotherapy Sensitive: C3 – Early Trials
EGFR exon 20 mutation EGFR exon 20 mutation	Non Small Cell Lung Cancer NSCLC	EGFR exon 20 mutation EGFR exon 20 mutation	Non Small Cell Lung Cancer NSCLC	icotinib Sensitive: C3 – Early Trials	icotinib Sensitive: C3 – Early Trials
EGFR exon 20 mutation EGFR exon 20 mutation	Non Small Cell Lung Cancer NSCLC	EGFR exon 20 mutation EGFR exon 20 mutation	Non Small Cell Lung Cancer NSCLC	afatinib Sensitive: C3 – Early Trials	afatinib Sensitive: C3 – Early Trials